Details of Epigenetic Molecule(EM)
General Information of EM (ID: EM00030) | |||||||
---|---|---|---|---|---|---|---|
Official Symbol |
HIST1H4A
|
||||||
Official Full Name |
histone cluster 1, H4a
|
||||||
Synonym |
FO108;H4;H4.k;H4/A;H4/I;H4/b;H4/c;H4/d;H4/e;H4/g;H4/h;H4/j;H4/k;H4/m;H4/n;H4/o;H4/p;H4F2;H4F2iii;H4F2iv;H4FA;H4FB;H4FC;H4FD;H4FE;H4FG;H4FH;H4FI;H4FJ;H4FK;H4FM;H4FN;H4M;HIST1H4L;HIST2H4;dJ160A22.1;dJ160A22.2;dJ221C16.1;dJ221C16.9
|
||||||
Molecule Type |
Protein coding
|
||||||
Position On Chromosome |
chr6(Start:26021907 - End:26022278)
|
||||||
Strand |
+
|
||||||
Uniprot Entry | |||||||
ENSG ID | |||||||
Dnmivd Disease | |||||||
Disease Relevance (Click to Show/Hide) | |||||||
5B81: Obesity | Obesity [Obesity] | ||||||
Detailed Information |
Disease Link
![]() |
||||||
6E8Z: Mental, behavioural or neurodevelopmental disorders | Psychiatric disorders [Mental, behavioural or neurodevelopmental disorders] | ||||||
Detailed Information |
Disease Link
![]() |
||||||
8A20: Alzheimer disease | Alzheimer's disease [Alzheimer disease] | ||||||
Detailed Information |
Disease Link
![]() |
||||||
XB8M: Congenital | Melanoma [Congenital] | ||||||
Detailed Information |
Disease Link
![]() |
||||||
XH7PW5: Lymphocytic leukaemia | Pediatric acute lymphoblastic [Lymphocytic leukaemia] | ||||||
Detailed Information |
Disease Link
![]() |
||||||
XH8P29: Medulloblastoma | Medulloblastoma [Medulloblastoma] | ||||||
Detailed Information |
Disease Link
![]() |
||||||
XH9HQ1: Gastrointestinal stromal tumour | Gastrointestinal stromal tumors [Gastrointestinal stromal tumour] | ||||||
Detailed Information |
Disease Link
![]() |
Metabolite(s) with this epigenetic modification | |||||||
---|---|---|---|---|---|---|---|
Metabolite Name: equol | |||||||
Detailed Information |
Meta Info
![]() |
[1], [2] | |||||
Description |
Equol has been shown to increaserepressive histone marks such as H4K8acat the promoter of ER-alpha.
|
||||||
Metabolite Name: Lipopolysaccharide | |||||||
Detailed Information |
Meta Info
![]() |
[1], [3] | |||||
Description |
Lipopolysaccharide has been shown to induce histone H4 acetylation.
|
||||||
Metabolite Name: Acetate | |||||||
Detailed Information |
Meta Info
![]() |
[1], [4] | |||||
Description |
Acetate has been shown to result in the increase in histone H4 acetylation
|
||||||
Metabolite Name: Acetate | |||||||
Detailed Information |
Meta Info
![]() |
[5], [6] | |||||
Description |
Acetate has been shown to increase acetylation of the histone H4 at the Foxp3 promoter.
|
||||||
Metabolite Name: Butyrate | |||||||
Detailed Information |
Meta Info
![]() |
[5], [4] | |||||
Description |
Butyrate has been shown to result in the increase in histone H4 acetylation
|
||||||
Metabolite Name: Iso-butyrate | |||||||
Detailed Information |
Meta Info
![]() |
[7], [8] | |||||
Description |
isobutyrate couldincreased lysine isobutyrylation levels on histones H4 at lysine.
|
||||||
Metabolite Name: Propionate | |||||||
Detailed Information |
Meta Info
![]() |
[9] | |||||
Description |
Propionate has been shown to result in the increase in histone H4 acetylation
|
||||||
Metabolite Name: Benzoate | |||||||
Detailed Information |
Meta Info
![]() |
[9], [10] | |||||
Description |
Benzoate has been shown to enhance the H4K16 benzoylation levels in HepG2 cells.
|
||||||
Metabolite Name: Benzoate | |||||||
Detailed Information |
Meta Info
![]() |
[9], [10] | |||||
Description |
Benzoate has been shown to enhance the H4K8 benzoylation levels in HepG2 cells.
|
||||||
Metabolite Name: Benzoate | |||||||
Detailed Information |
Meta Info
![]() |
[9], [10] | |||||
Description |
Benzoate has been shown to enhance the H4K5 benzoylation levels in HepG2 cells.
|
||||||
Metabolite Name: Benzoate | |||||||
Detailed Information |
Meta Info
![]() |
[9], [10] | |||||
Description |
Benzoate has been shown to enhance the H4K12 benzoylation levels in HepG2 cells.
|
||||||
Metabolite Name: Biotin (B7) | |||||||
Detailed Information |
Meta Info
![]() |
[9], [10] | |||||
Description |
Biotinylation is an epigenetic process in which gene expression is repressed by covalent attachment of biotin on histone H4 at K8
|
||||||
Metabolite Name: Niacin (B3) | |||||||
Detailed Information |
Meta Info
![]() |
[9], [10] | |||||
Description |
Niacin (B3) could increase histone H4 acetylation at the FXN gene in friedreich's ataxia.
|
||||||
Metabolite Name: Biotin (B7) | |||||||
Detailed Information |
Meta Info
![]() |
[2], [11] | |||||
Description |
Biotin (B7) has been shown to increase the level of K12Bio H4 at SMVT promoter 1.
|
||||||
Metabolite Name: equol | |||||||
Detailed Information |
Meta Info
![]() |
[2], [11] | |||||
Description |
Equol has been shown to increaserepressive histone marks such as H4K8ac at the promoter of ER-BETA.
|
||||||
Metabolite Name: Lipopolysaccharide | |||||||
Detailed Information |
Meta Info
![]() |
[2], [11] | |||||
Description |
Lipopolysaccharide has been shown to induce histone H4 acetylation.
|
||||||
Metabolite Name: Flagellin | |||||||
Detailed Information |
Meta Info
![]() |
[12] | |||||
Description |
Legionella pneumophila-induced acetylation of H4 at the IL-8 promoter depended on flagellin.
|
||||||
Metabolite Name: equol | |||||||
Detailed Information |
Meta Info
![]() |
[13], [14] | |||||
Description |
Equol has been shown to increaserepressive histone marks such as H4K8acat the promoter of BRCA1.
|
||||||
Metabolite Name: equol | |||||||
Detailed Information |
Meta Info
![]() |
[13], [14] | |||||
Description |
Equol has been shown to increase repressive histone marks such as H4K8ac at the promoter of BRCA1.
|
||||||
Metabolite Name: equol | |||||||
Detailed Information |
Meta Info
![]() |
[13], [14] | |||||
Description |
Equol has been shown to increase repressive histone marks such as H4K8ac at the promoter of ER-alpha.
|
||||||
Metabolite Name: equol | |||||||
Detailed Information |
Meta Info
![]() |
[13], [14] | |||||
Description |
Equol has been shown to increase repressive histone marks such as H4K8ac at the promoter of ER-BETA.
|
||||||
Metabolite Name: equol | |||||||
Detailed Information |
Meta Info
![]() |
[13], [14] | |||||
Description |
Equol has been shown to increaserepressive histone marks such as H4K8acat the promoter of EZH2.
|
||||||
Metabolite Name: equol | |||||||
Detailed Information |
Meta Info
![]() |
[13], [14] | |||||
Description |
Equol has been shown to increase repressive histone marks such as H4K8ac at the promoter of EZH2.
|
||||||
Metabolite Name: equol | |||||||
Detailed Information |
Meta Info
![]() |
[13], [14] | |||||
Description |
Equol has been shown to increaserepressive histone marks such as H4K8acat the promoter of P300.
|
||||||
Metabolite Name: equol | |||||||
Detailed Information |
Meta Info
![]() |
[13], [14] | |||||
Description |
Equol has been shown to increase repressive histone marks such as H4K8ac at the promoter of P300.
|
||||||
Metabolite Name: equol | |||||||
Detailed Information |
Meta Info
![]() |
[13], [14] | |||||
Description |
Equol has been shown to increaserepressive histone marks such as H4K8acat the promoter of SRC3.
|
||||||
Metabolite Name: equol | |||||||
Detailed Information |
Meta Info
![]() |
[13], [14] | |||||
Description |
Equol has been shown to increase repressive histone marks such as H4K8ac at the promoter of SRC3.
|
||||||
Metabolite Name: Valerate | |||||||
Detailed Information |
Meta Info
![]() |
[15], [4] | |||||
Description |
Valerate has been shown to result in the increase in histone H4 acetylation
|
||||||
Metabolite Name: Phenylbutyrate | |||||||
Detailed Information |
Meta Info
![]() |
[16], [17] | |||||
Description |
Phenylbutyrate has been shown to induce increased histones H4 acetylation in D283-MED cells.
|
Protein(s) with this epigenetic modification | |||||||
---|---|---|---|---|---|---|---|
Protein Name: NuE | |||||||
Detailed Information |
Pro Info
![]() |
[18] | |||||
Description |
NuE could methylates H4.
|
||||||
Protein Name: Listeriolysin O | |||||||
Detailed Information |
Pro Info
![]() |
[19] | |||||
Description |
Listeriolysin O(LLO) has been shown to induce a drastic deacetylation of H4.
|
||||||
Protein Name: Rv3763 | |||||||
Detailed Information |
Pro Info
![]() |
[20] | |||||
Description |
Rv3763 could inhibite the increased acetylation of histones H4 at CIITA pIV locus.
|
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.